Old Web
English
Sign In
Acemap
>
authorDetail
>
Lilli Petruzzelli
Lilli Petruzzelli
Millennium Pharmaceuticals
Immunology
Rituximab
Medicine
In vivo
Lymphoma
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pre-Clinical Antitumor activity of MLN4924, An Inhibitor of NEDD8-Activating Enzyme (NAE), in a Novel Primary Human DLBCL Xenograft Model.
2009
Blood
Tary Traore
James J. Garnsey
Erik Koenig
Allison Berger
Mark Manfredi
Lilli Petruzzelli
Peter G. Smith
Show All
Source
Cite
Save
Citations (2)
Abstract B189: The Nedd8‐activating enzyme inhibitor MLN4924 combined with rituximab induces additive/synergistic anti‐tumor activity in preclinical non‐Hodgkin's lymphoma models
2009
Molecular Cancer Therapeutics
Derek Tou
Tary Traore
Michael D. Pickard
Sai Pulukuri
Mark Manfredi
Lilli Petruzzelli
Allison Berger
Peter G. Smith
Show All
Source
Cite
Save
Citations (0)
Phase 1 Dose-Escalation Study of MLN4924, a Novel NAE Inhibitor, in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.
2009
Blood
Jatin J. Shah
Andrzej Jakubowiak
Owen O’Connor
Robert Z. Orlowski
Molly Patterson
Donald Harvey
Allison Berger
Alice McDonald
George Mulligan
Lilli Petruzzelli
Michael D. Pickard
Peter G. Smith
Karthik Venkatakrishnan
Sagar Lonial
Show All
Source
Cite
Save
Citations (6)
1